EP3889145
8-Sýanó-5-píperidínó-kínólín sem TLR7/8 mótlyf og notkun þeirra við meðhöndlun á ónæmisröskunum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.12.2016EP published:
21.2.2024EP application number:
21172996.7
EP translation filed:
29.4.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
15.12.2036Expiry date:
15.12.2026Next due date:
31.12.2026
Title in English:
8-CYANO-5-PIPERIDINO-QUINOLINES AS TLR7/8 ANTAGONISTS AND THEIR USES FOR TREATING IMMUNE DISORDERSLanguage of the patent:
English
Timeline
Today
16.12.2016EP application
21.2.2024EP Publication
29.4.2024Translation submitted
15.6.2024Registration published
15.12.2026Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293 Darmstadt, DE
Inventor
Name:
Sherer, BrianAddress:
Billerica, MA 01821-3936, US
Name:
Brugger, NadiaAddress:
Burlington, MA 01803, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562268765 PDate:
17.12.2015Country:
US
Number:
201662353603 PDate:
23.6.2016Country:
US
Classification
Categories:
C07D 401/04, A61K 31/4709, A61P 37/00, A61P 29/00, A61P 3/10, A61P 9/10, A61P 17/06, A61P 19/00, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 5.11.2024
Expires: 15.12.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.12.2025
Expires: 15.12.2026
Payer: Árnason Faktor ehf.